INTRODUCTION: While waterpipe tobacco smoking has become a global phenomenon, its potential health consequences are poorly understood. In this manuscript, we report the in vitro mutagenicity of waterpipe smoke condensate (WSC), the alteration in cellular parameters of lung alveolar cells in response to WSC exposure and discuss the implication of cellular responses in the pathophysiology of chronic obstructive pulmonary disease (COPD). METHODS: The mainstream WSC was generated using a standard laboratory machine protocol. We assessed its mutagenicity using Ames test. In addition, we studied the effect of WSC on the proliferation and cell cycle of alveolar type II cells and vascular endothelial cells. We also assessed the effect of WSC on the expression of genes involved in cell cycle arrest and inflammation. RESULTS: Within the range of tested doses, WSC did not elicit sufficient response to be considered mutagenic in any of the strains tested (TA98, TA100, TA102, and TA97a) but were found to be toxic for strains TA97a and TA102 at the highest tested doses. However, WSC induced cell cycle arrest and cellular senescence mediated by the p53-p21 pathway. Also our study indicated that WSC induced an increase in the transcriptional expression of matrix metalloproteinases, MMP-2 and MMP-9 and an immune response regulator, Toll Like Receptor-4. CONCLUSION: The data reported here represent the first in vitro demonstration of the effect of waterpipe smoke on cellular parameters providing evidence of the potential involvement of WPS in the pathogenesis of COPD through impairing cellular growth and inducing inflammation.
INTRODUCTION: While waterpipe tobacco smoking has become a global phenomenon, its potential health consequences are poorly understood. In this manuscript, we report the in vitro mutagenicity of waterpipe smoke condensate (WSC), the alteration in cellular parameters of lung alveolar cells in response to WSC exposure and discuss the implication of cellular responses in the pathophysiology of chronic obstructive pulmonary disease (COPD). METHODS: The mainstream WSC was generated using a standard laboratory machine protocol. We assessed its mutagenicity using Ames test. In addition, we studied the effect of WSC on the proliferation and cell cycle of alveolar type II cells and vascular endothelial cells. We also assessed the effect of WSC on the expression of genes involved in cell cycle arrest and inflammation. RESULTS: Within the range of tested doses, WSC did not elicit sufficient response to be considered mutagenic in any of the strains tested (TA98, TA100, TA102, and TA97a) but were found to be toxic for strains TA97a and TA102 at the highest tested doses. However, WSC induced cell cycle arrest and cellular senescence mediated by the p53-p21 pathway. Also our study indicated that WSC induced an increase in the transcriptional expression of matrix metalloproteinases, MMP-2 and MMP-9 and an immune response regulator, Toll Like Receptor-4. CONCLUSION: The data reported here represent the first in vitro demonstration of the effect of waterpipe smoke on cellular parameters providing evidence of the potential involvement of WPS in the pathogenesis of COPD through impairing cellular growth and inducing inflammation.
Authors: Brian A Primack; Ariel Shensa; Kevin H Kim; Mary V Carroll; Mary T Hoban; E Victor Leino; Thomas Eissenberg; Kathleen H Dachille; Michael J Fine Journal: Nicotine Tob Res Date: 2012-05-28 Impact factor: 4.244
Authors: D J Doolittle; C K Lee; J L Ivett; J C Mirsalis; E Riccio; C J Rudd; G T Burger; A W Hayes Journal: Mutat Res Date: 1990-02 Impact factor: 2.433
Authors: Jens Schubert; Jürgen Hahn; Gerhard Dettbarn; Albrecht Seidel; Andreas Luch; Thomas G Schulz Journal: Toxicol Lett Date: 2011-06-25 Impact factor: 4.372
Authors: Maged El-Setouhy; Christopher A Loffredo; Ghada Radwan; Rehab Abdel Rahman; Eman Mahfouz; Ebenezer Israel; Mostafa K Mohamed; Sohair B A Ayyad Journal: Mutat Res Date: 2008 Aug-Sep Impact factor: 2.433
Authors: Najla S Dar-Odeh; Faris G Bakri; Mahmoud K Al-Omiri; Hamzeh M Al-Mashni; Hazem A Eimar; Ameen S Khraisat; Shatha Mk Abu-Hammad; Abdul-Aziz F Dudeen; Mohamed Nur Abdallah; Samer M Zied Alkilani; Louai Al-Shami; Osama A Abu-Hammad Journal: Harm Reduct J Date: 2010-05-24
Authors: Caroline O Cobb; Melissa D Blank; Alejandra Morlett; Alan Shihadeh; Ezzat Jaroudi; Nareg Karaoghlanian; Barbara Kilgalen; Janet Austin; Michael F Weaver; Thomas Eissenberg Journal: Nicotine Tob Res Date: 2014-09-25 Impact factor: 4.244
Authors: Yashodhar P Bhandary; Shwetha K Shetty; Amarnath S Marudamuthu; Hong-Long Ji; Pierre F Neuenschwander; Vijay Boggaram; Gilbert F Morris; Jian Fu; Steven Idell; Sreerama Shetty Journal: Am J Pathol Date: 2013-05-08 Impact factor: 4.307
Authors: Gideon St Helen; Neal L Benowitz; Katherine M Dains; Christopher Havel; Margaret Peng; Peyton Jacob Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-05-16 Impact factor: 4.254